Literature DB >> 19153465

Structure of relaxed-state human hemoglobin: insight into ligand uptake, transport and release.

Joy D Jenkins1, Faik N Musayev, Richmond Danso-Danquah, Donald J Abraham, Martin K Safo.   

Abstract

Hemoglobin was one of the first protein structures to be determined by X-ray crystallography and served as a basis for the two-state MWC model for the mechanism of allosteric proteins. Since then, there has been an ongoing debate about whether Hb allostery involves the unliganded tense T state and the liganded relaxed R state or whether it involves the T state and an ensemble of liganded relaxed states. In fact, the former model is inconsistent with many functional observations, as well as the recent discoveries of several relaxed-state Hb structures such as RR2, R3 and R2. One school of thought has suggested the R2 state to be the physiologically relevant relaxed end state, with the R state mediating the T-->R2 transition. X-ray studies have been performed on human carbonmonoxy Hb at a resolution of 2.8 A. The ensuing liganded quaternary structure is different from previously reported liganded Hb structures. The distal beta-heme pocket is the largest when compared with other liganded Hb structures, partly owing to rotation of betaHis63(E7) out of the distal pocket, creating a ligand channel to the solvent. The structure also shows unusually smaller alpha- and beta-clefts. Results from this study taken in conjunction with previous findings suggest that multiple liganded Hb states with different quaternary structures may be involved in ligand uptake, stabilization, transport and release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19153465     DOI: 10.1107/S0907444908037256

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  13 in total

1.  Blocking the gate to ligand entry in human hemoglobin.

Authors:  Ivan Birukou; Jayashree Soman; John S Olson
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

2.  Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.

Authors:  Piyusha P Pagare; Mohini S Ghatge; Faik N Musayev; Tanvi M Deshpande; Qiukan Chen; Courtney Braxton; Solyi Kim; Jürgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Bioorg Med Chem       Date:  2018-04-06       Impact factor: 3.641

3.  Structures and oxygen affinities of crystalline human hemoglobin C (β6 Glu->Lys) in the R and R2 quaternary structures.

Authors:  Naoya Shibayama; Kanako Sugiyama; Sam-Yong Park
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

4.  Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.

Authors:  Tanvi M Deshpande; Piyusha P Pagare; Mohini S Ghatge; Qiukan Chen; Faik N Musayev; Jurgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

5.  Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.

Authors:  Osheiza Abdulmalik; Mohini S Ghatge; Faik N Musayev; Apurvasena Parikh; Qiukan Chen; Jisheng Yang; Ijeoma Nnamani; Richmond Danso-Danquah; Dorothy N Eseonu; Toshio Asakura; Donald J Abraham; Jurgen Venitz; Martin K Safo
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-10-19

6.  Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation.

Authors:  Mohini S Ghatge; Mostafa H Ahmed; Abdel Sattar M Omar; Piyusha P Pagare; Susan Rosef; Glen E Kellogg; Osheiza Abdulmalik; Martin K Safo
Journal:  J Struct Biol       Date:  2016-04-13       Impact factor: 2.867

Review 7.  New look at hemoglobin allostery.

Authors:  Yue Yuan; Ming F Tam; Virgil Simplaceanu; Chien Ho
Journal:  Chem Rev       Date:  2015-01-21       Impact factor: 60.622

Review 8.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

Review 9.  New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Authors:  Esther Oder; Martin K Safo; Osheiza Abdulmalik; Gregory J Kato
Journal:  Br J Haematol       Date:  2016-09-08       Impact factor: 6.998

10.  Structure of fully liganded Hb ζ2β2s trapped in a tense conformation.

Authors:  Martin K Safo; Tzu-Ping Ko; Osheiza Abdulmalik; Zhenning He; Andrew H-J Wang; Eric R Schreiter; J Eric Russell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.